Showing results (61-70 of 15,777) with videos related to
Sort By:
Pageof 1,578
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 1, 1995
Prognostic significance of magnetic resonance imaging in patients with asymptomatic multiple myelomaL A Moulopoulos, M A Dimopoulos, T L Smith, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 15, 2002
Consolidation therapy of multiple myeloma with thalidomide-dexamethasone after intensive chemotherapyR Alexanian, D Weber, S Giralt, et al.Blood|April 1, 1988
Phenotypic heterogeneity in aneuploid multiple myeloma indicates pre-B cell involvementJ Epstein, B Barlogie, J Katzmann, et al.Canadian Medical Association Journal|March 6, 1971
Immune function in multiple myeloma: impaired responsiveness to keyhole limpet hemocyaninJ Harris, R Alexanian, E Hersh, et al.Annals of Internal Medicine|April 1, 1989
High serum levels of lactic dehydrogenase identify a high-grade lymphoma-like myelomaB Barlogie, L Smallwood, T Smith, et al.Leukemia & Lymphoma|September 1, 1995
VAD-cyclosporine therapy for VAD-resistant multiple myelomaD Weber, M Dimopoulos, F Sinicrope, et al.Hematology (Amsterdam, Netherlands)|April 29, 2010
Rapid control of previously untreated multiple myeloma with bortezomib-lenalidomide-dexamethasone (BLD)M Wang, K Delasalle, S Giralt, et al.Blood|March 1, 1989
Plasma cell myeloma--new biological insights and advances in therapyB Barlogie, J Epstein, P Selvanayagam, et al.Blood|September 1, 1983
Prednisone pulse therapy for refractory myelomaR Alexanian, B S Yap, G P BodeyThe International Journal of Biochemistry & Cell Biology|May 14, 2013
Enhancing the efficiency of direct reprogramming of human mesenchymal stem cells into mature neuronal-like cells with the combination of small molecule modulators of chromatin modifying enzymes, SMAD signaling and cyclic adenosine monophosphate levelsArshak R Alexanian, Qing-song Liu, Zhiying ZhangPageof 1,578